Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Journal of Kermanshah University of Medical Sciences
  4. Articles

  5. Effects of adding dexmedetomidine to lidocaine on the onset and duration of axillary block for upper extremity surgeries
  6. Scopus by Title (Ref)

Journal of Kermanshah University of Medical Sciences

Peer-reviewed Medical Quarterly

Home
Current IssueAll IssuesIn PressAccepted ManuscriptsSearch
Instructions
Journal InformationBoards and CommitteesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Efficacy of Neostigmine as an Adjuvant to Ropivacaine in Axillary Brachial Plexus Block for Hand and Forearm Surgery: A Randomized, Double-Blind Clinical Trial

- Hemati K. , et al.

2. Alpha2-receptor agonists as adjuvants for brachial plexus nerve blocks—A systematic review with meta-analyses

- Andersen J.H. , et al.

3. Clinical Comparison of Adding Sulfate Magnesium and Dexmedetomidine in Axillary Plexus Block for Prolonging the Duration of Sensory and Motor Block: Study Protocol for a Double-blind Randomized Clinical Trial

- Shahtaheri S.Y. , et al.

HomeInstructions

Articles

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Boards and Committees
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.